Mark Chalmers, PhD
Principal, EU Lead
Dr. Chalmers brings a wealth of pricing, market access, and value demonstration experience with clients throughout Europe and North America. While he has working knowledge of all global Pricing & Market Access and Value Demonstration issues, he particularly excels at pricing and market access strategy, value message / story development, and payer negotiation strategy in Europe.
Dr. Chalmers has worked with clients in the pharmaceutical and biotech industries for over 10 years to address critical commercial strategic issues, including therapeutic area and market assessments, clinical trial design optimization, value proposition and message development, pricing, reimbursement, market access strategies, contracting strategies, and lifecycle management.